Temporal relationship between prevalence of meticillin-resistant Staphylococcus aureus (MRSA) in one hospital and prevalence of MRSA in the surrounding community: a time-series analysis

Journal of Hospital Infection

Volumn 67, Issue 3, 2007, Pages 225-231

  MacKenzie, F M ^a   Lopez Lozano, J M ^b   Monnet, D L ^c   Stuart, D ^a   Beyaert, A ^d   Wilson, R ^a   Gould, I M ^a  

^a ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^b HOSPITAL VEGA BAJA   (Spain)

^c STATENS SERUM INSTITUT   (Denmark)

^d UNIVERSITY OF MURCIA   (Spain)

Author keywords

Community; Hospital; MRSA; Prevalence; Time series analysis

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; BETA LACTAMASE INHIBITOR; CEPHALOSPORIN DERIVATIVE; MACROLIDE; PENICILLIN DERIVATIVE; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULFONAMIDE; TETRACYCLINE DERIVATIVE;

ANTIBIOTIC RESISTANCE; ARTICLE; COMMUNICABLE DISEASE; CONTROLLED STUDY; DRUG USE; EPIDEMIC; HOSPITAL DISCHARGE; HOSPITAL INFECTION; HUMAN; INCIDENCE; INFECTION CONTROL; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PREVALENCE; REGRESSION ANALYSIS; STAPHYLOCOCCUS INFECTION; TIME SERIES ANALYSIS; UNITED KINGDOM;

ANTI-INFECTIVE AGENTS; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; DISEASE OUTBREAKS; DRUG UTILIZATION; GREAT BRITAIN; HUMANS; METHICILLIN RESISTANCE; PREVALENCE; REGRESSION ANALYSIS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; STATISTICS AS TOPIC; TIME FACTORS;

EID: 35648999438     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhin.2007.07.011     Document Type: Article

References (16)

1. Muto C.A., Jernigan J.A., Ostrowsky B.E., et al. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and Enterococcus. Infect Control Hosp Epidemiol 24 (2003) 362-386
2. Salgado C.D., Farr B.M., and Calfee D.P. Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors. Clin Infect Dis 36 (2003) 131-139
3. Charlebois E.D., Perdreau-Remington F., Kreiswirth B., et al. Origins of community strains of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 39 (2004) 47-54
4. Murray R.J., Lim T.T., Pearson J.C., Grubb W.B., and Lum G.D. Community-onset methicillin-resistant Staphylococcus aureus bacteremia in Northern Australia. Int J Infect Dis 8 (2004) 275-283
5. Johnsson D., Mo{combining double acute accent}lling P., Strållin K., and So{combining double acute accent}derquist B. Detection of Panton-Valentine leukocidin gene in Staphylococcus aureus by LightCycler PCR: clinical and epidemiological aspects. Clin Microbiol Infect 10 (2004) 884-889
6. Vandenesch F., Naimi T., Enright M., et al. Community-acquired methicillin resistant Staphylococcus aureus carrying panton-valentine leukocidin genes: worldwide emergence. Emerg Infect Dis 9 (2003) 978-984
7. Monnet D.L., MacKenzie F.M., López-Lozano J.M., et al. Antimicrobial drug use and methicillin-resistant Staphylococcus aureus, Aberdeen, 1996-2000. Emerg Infect Dis 10 (2004) 1432-1441
8. Gould IM, Monnet DL, MacKenzie FM, Lopez-Lozano JM. Relationship between methicillin resistant S. aureus (MRSA) isolates in two Scottish hospitals: a time series analysis. Poster 1395, Presented at the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2003.
9. MacKenzie F.M., López-Lozano J.-M., Monnet D.L., et al. Relationship between methicillin-resistant S. aureus outbreaks in two Scottish hospitals. Proceedings & Abstracts of the 13th European Congress of Clinical Microbiology & Infectious Diseases, Glasgow, 10-13 May 2003. Clin Microbiol Infect 9 Suppl. 1 (2003) 60
10. MacKenzie F.M., and Gould I.M. Quantitative measurement of antibiotic use. In: Gould I.M., and van der Meer J.W.M. (Eds). Antibiotic policies - Theory and Practice (2004), Kluwer Academic/Plenum Publishers, New York Chap. 7, 105-118
11. Greene W.H. Regression with lagged variables. Econometric Analysis. 4th edn (2000), Prentice-Hall, New Jersey, USA Chap. 17, 718-720
12. Lopez-Lozano JM, Beyaert A, MacKenzie FM, et al. Effect of an intervention programme on the MRSA outbreak in Aberdeen Royal Infirmary. Poster P571. Presented at the 14th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Prague, 2004.
13. Cars O., Mölstad S., and Melander A. Variation in antibiotic use in the European Union. Lancet 357 (2001) 1851-1853
14. Gould I.M., Clarke R., Hutchinson S., and Davey P. Variation in antibiotic use in the European union. Lancet 358 (2001) 1273
15. Dupeyron C., Campillo B., Bordes M., Faubert E., Richardet J.-P., and Mangeney N. A clinical trial of mupirocin in the eradication of methicillin-resistant Staphylococcus aureus nasal carriage in a digestive disease unit. J Hosp Infect 52 (2002) 281-287
16. Dryden M.S., Dailly S., and Crouch M. A randomised control trial of tea tree topical preparations versus a standard topical regimen for the clearance of MRSA colonisation. J Hosp Infect 56 (2004) 283-286